Diastolic dysfunction

Critical Care Nursing Clinics of North America

Volumn 15, Issue 4, 2003, Pages 495-500

  Paul, Sara ^a,b  

^a Hickory Cardiology Associates   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; NITRATE; SPIRONOLACTONE; TROPONIN C; VERAPAMIL;

CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC TEST; DIASTOLE; EVIDENCE BASED MEDICINE; EXPERIENCE; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; KINESIOTHERAPY; LUNG CONGESTION; LUNG EDEMA; MORTALITY; PERIPHERAL EDEMA; PRACTICE GUIDELINE; REVIEW; SYSTOLE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; CONGESTIVE HEART FAILURE; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME;

DIASTOLE; HEART FAILURE, CONGESTIVE; HUMANS; PRACTICE GUIDELINES; PROGNOSIS; PULMONARY EDEMA; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 1442285456     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-5885(02)00090-4     Document Type: Review

References (39)

1. McCullough P., Philbin E., Spertus J., et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 39:2002;60-69
2. Walker K., Thompson D. Diastolic heart failure. Taylor G. Primary care management of heart disease. 2000;276-287 Mosby, St. Louis
3. Zile M. Diastolic dysfunction: detection, consequences, and treatment. Part 1: definition and determinants of diastolic function. American Heart Association's Modern Concepts of Cardiovascular Disease. 58:1989;67-72
4. Vasan R., Larson M., Benjamin E., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population- based cohort. J Am Coll Cardiol. 33:1999;1948-1955
5. Elesber A., Redfield M. Approach to patients with heart failure and normal ejection fraction. Mayo Clin Proc. 76:2001;1047-1052
6. Vasan R., Benjamin E., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 26:1995;1565-1574
7. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. Importance of heart failure with preserved systolic function in patients >/=65 years of age. Am J Cardiol. 87:2001;413-419
8. Philbin E., Rocco T., Lindenmuth N., et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med. 109:2000;605-613
9. Devereux R., Roman M., Liu J., et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol. 86:2000;1090-1096
10. Dauterman K., Massie B., Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J. 135:1998;S310-S319
11. Senni M., Redfield M. Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol. 38:2001;1277-1282
12. Cohn J., Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation. 81:1990;III48-III53
13. Rodeheffer R.J., Jacobsen S.J., Gersh B.J., et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc. 68:1993;1143-1150
14. Soufer R., Wohlgelernter D., Vita N., et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol. 55:1985;1032-1036
15. Dougherty A., Naccarelli G., Gray E., et al. Congestive heart failure with normal systolic function. Am J Cardiol. 54:1984;778-782
16. Cohen G., Pietrolungo J., Thomas J., et al. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol. 27:1996;1753-1760
17. Bonow R., Udelson J. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med. 117:1992;502-510
18. Apstein C., Morgan J. Cellular mechanisms of diastolic dysfunction. 10.1 ed: www.uptodate.com. Accessed 8/29/02
19. Applegate R., Walsh R., O'Rourke R. Effects of nifedipine on diastolic function during brief periods of flow-limiting ischemia in the conscious dog. Circulation. 76:1987;1409-1421
20. Apstein C. Diagnosis, treatment, and prognosis of diastolic dysfunction. 10.1 ed: www.uptodate.com. Accessed 8/29/02
21. Zile M., Gaasch W., Carroll J.D., et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 104:2001;779-782
22. Hunt S., Baker D., Chin M., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) developed in collaboration with the International Society for Heart and Lung Transplantation endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 38:2001;2101-2113
23. Andersson B., Caidahl K., diLenarda A., et al. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation. 94:1996;673-682
24. Setaro J., Zaret B., Schulman D., et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol. 66:1990;981-986
25. Bonow R., Dilsizian V., Rosing D., et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation. 72:1985;853-864
26. Hopf R., Kaltenbach M. 10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists. Z Kardiol. 76:1987;137-144
27. Friedrich S., Lorell B., Rousseau M., et al. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation. 90:1994;2761-2771
28. Warner J., Metzger D., Kitzman D., et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol. 33:1999;1567-1572
29. Schmieder R., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 275:1996;1507-1513
30. Aronow W., Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol. 71:1993;602-604
31. Weinberg E., Lee M., Weigner M., et al. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation. 95:1997;1592-1600
32. Massie B. Heart failure in patients with preserved left ventricular systolic function: do digitalis glycosides have a role? Prog Cardiovasc Dis. 40:1998;357-369
33. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533
34. Braith R., Welsch M., Feigenbaum M., et al. Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol. 34:1999;1170-1175
35. Kiilavuaori K., Naveri H., Leinonen H., et al. The effect of physical training on hormonal status and exertional response in patients with congestive heart failure. Eur J Cardiol. 20:1999;456-464
36. Coats A., Adamopoulos S., Radaelli A., et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation. 85:1992;2119-2131
37. Willenheimer R., Erhardt L., Cline C., et al. Exercise training in heart failure improves quality of life and exercise capacity. Eur Heart J. 19:1998;774-781
38. Mandinov L., Eberli F., Seiler C., et al. Diastoic heart failure. Cardiovasc Res. 45:2000;813-825
39. O'Connor C., Gattis W., Shaw L., et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol. 86:2000;863-867